TRENTON, N.J. and WAYNE, Pa. — Merck Executive Vice President and Chief Medical Officer Michael Rosenblatt will discuss the barriers to innovation in the life sciences during a luncheon keynote address on Oct. 24 at Biotech 2011, the mid-Atlantic region’s premier bioscience conference, according to a press release.
Biotech 2011, which will be held Oct. 24-25 in Philadelphia, brings together leaders in the bio science, finance and academic communities to share business strategies and learn from their peers through a series of forums and panels.
In his presentation, “The Barriers to Life Science Innovation: Don’t Think Biotech is Immune,” Dr. Rosenblatt will discuss the future of innovation in the life sciences.
“There’s no denying that we are in a challenging period of innovation for new drugs. The biopharma industry’s R&D spend grew by 150 percent from 1998 to 2008, while the number of new molecular entities and biologics introduced fell by 35 percent,” said Dr. Rosenblatt.
“Some blame industry itself for this decline, some say the whole system isn’t working. Whatever the reasons, it would be a mistake to think that any of us are immune to these forces, or that the problem can be solved without all of us working together,” he added.